EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-nutritive sweeteners, the gut microbiome, and tumor immunity: evidence hierarchy and a sucralose-centered translational model

Jie Li, Deng-Hua Li, Yu-Hao Liu, Yan-Peng Zhang, Qi-Qi Guo, Xiao-Jing Zhu, Yu-Run Wang, Yong-Quan Shi

Frontiers in Nutrition · 18.08.2026 · 13

DOI: 10.3389/fnut.2026.1868431 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nutrition, online erschienen am 18.08.2026. Verfasst von Jie Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Dep…. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People’s Republic of China, Shaanxi Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-nutritive sweeteners (NNS) are widely used sugar substitutes and constitute heterogeneous dietary and non-dietary exposures. Human gut microbiota findings vary by sweetener identity, purified compound versus commercial formulation, carrier ingredients, dose, duration, host background, and analytical method. Purified compounds and commercial formulations are therefore biologically non-equivalent. A structured narrative search of PubMed, Embase, and the Web of Science Core Collection was conducted from database inception through 17 July 2026 without language restrictions. Evidence was organized by directness to the clinical question and translational distance. Direct human evidence relating NNS exposure to immune checkpoint inhibitor (ICI) outcomes remains observational and sucralose-centered. Experimental evidence for gut microbiota involvement, arginine-related mediation, and reversibility derives mainly from preclinical models; comparable class-wide evidence is lacking. No prospective evidence currently supports NNS-specific dietary modification during immune checkpoint inhibitor therapy. Validation requires prospective, sweetener-specific exposure assessment integrated with gut microbiota, metabolomic, and immune profiling.

Schlagwörter

Stichwörter der Autor:innen

evidence hierarchygut microbiomenon-nutritive sweetenerssucralosetumor immunity

Autor:innen und Institutionen

  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Department of Gastroenterology & Hepatology, Xijing Hospital, Fourth Mili…
  • Department of Postgraduate, Xi'an Medical University, Xi'an, Shaanxi, China.

Förderung

  • Ministry of Science and Technology of the People’s Republic of China
  • Shaanxi Provincial Health Commission

Zitieren

APA

Li, J., Li, D. H., Liu, Y. H., Zhang, Y. P., Guo, Q. Q., Zhu, X. J., Wang, Y. R., & Shi, Y. Q. (2026). Non-nutritive sweeteners, the gut microbiome, and tumor immunity: evidence hierarchy and a sucralose-centered translational model. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1868431

Vancouver

Li J, Li DH, Liu YH, Zhang YP, Guo QQ, Zhu XJ, et al. Non-nutritive sweeteners, the gut microbiome, and tumor immunity: evidence hierarchy and a sucralose-centered translational model. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1868431

BibTeX
@article{Li2026,
  author = {Li, Jie and Li, Deng-Hua and Liu, Yu-Hao and Zhang, Yan-Peng and Guo, Qi-Qi and Zhu, Xiao-Jing and Wang, Yu-Run and Shi, Yong-Quan},
  title = {Non-nutritive sweeteners, the gut microbiome, and tumor immunity: evidence hierarchy and a sucralose-centered translational model},
  journal = {Frontiers in Nutrition},
  year = {2026},
  volume = {13},
  doi = {10.3389/fnut.2026.1868431}
}
Kostenlos starten →